MA34819B1 - Dérivés bicyclo[3.2.1]octylamide et leurs utilisations - Google Patents
Dérivés bicyclo[3.2.1]octylamide et leurs utilisationsInfo
- Publication number
- MA34819B1 MA34819B1 MA36100A MA36100A MA34819B1 MA 34819 B1 MA34819 B1 MA 34819B1 MA 36100 A MA36100 A MA 36100A MA 36100 A MA36100 A MA 36100A MA 34819 B1 MA34819 B1 MA 34819B1
- Authority
- MA
- Morocco
- Prior art keywords
- octylamide
- bicyclo
- derivatives
- relates
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
La présente invention concerne des dérivés bicyclo[3.2.1 ]octylamide de formule (I) : dans laquelle L, R1 et R2 sont tels que définis ici, ou un de leurs sels pharmaceutiquement acceptables. L'invention concerne également des compositions pharmaceutiques et des procédés d'utilisation associés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061426379P | 2010-12-22 | 2010-12-22 | |
PCT/US2011/066690 WO2012088365A1 (fr) | 2010-12-22 | 2011-12-22 | Dérivés bicyclo[3.2.1]octylamide et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
MA34819B1 true MA34819B1 (fr) | 2014-01-02 |
Family
ID=46314466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA36100A MA34819B1 (fr) | 2010-12-22 | 2011-12-22 | Dérivés bicyclo[3.2.1]octylamide et leurs utilisations |
Country Status (29)
Country | Link |
---|---|
US (3) | US8921370B2 (fr) |
EP (2) | EP2654422B1 (fr) |
JP (2) | JP5992436B2 (fr) |
KR (1) | KR101840076B1 (fr) |
CN (2) | CN105348185B (fr) |
AP (1) | AP3758A (fr) |
AR (1) | AR084457A1 (fr) |
AU (2) | AU2011348188B2 (fr) |
BR (1) | BR112013015592A8 (fr) |
CA (1) | CA2821937A1 (fr) |
CO (1) | CO6741203A2 (fr) |
CR (1) | CR20130309A (fr) |
DO (1) | DOP2013000142A (fr) |
EA (1) | EA026362B1 (fr) |
EC (1) | ECSP13012788A (fr) |
GE (1) | GEP20156219B (fr) |
GT (1) | GT201300164A (fr) |
IL (1) | IL226981A (fr) |
MA (1) | MA34819B1 (fr) |
MX (2) | MX349132B (fr) |
MY (1) | MY169432A (fr) |
NZ (2) | NZ612000A (fr) |
PE (1) | PE20141529A1 (fr) |
SG (1) | SG191317A1 (fr) |
TN (1) | TN2013000253A1 (fr) |
TW (1) | TWI538905B (fr) |
UA (1) | UA109802C2 (fr) |
WO (1) | WO2012088365A1 (fr) |
ZA (2) | ZA201304624B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2013006706A0 (en) | 2010-07-02 | 2013-02-28 | Gilead Sciences Inc | Napht-2-ylacetic acid derivatives to treat AIDS |
EA201291301A1 (ru) | 2010-07-02 | 2013-05-30 | Джилид Сайэнс, Инк. | Производные 2-хинолинилуксусной кислоты в качестве противовирусных соединений против вич |
TWI538905B (zh) * | 2010-12-22 | 2016-06-21 | H 朗德貝克公司 | 雙環[3.2.1]辛基醯胺衍生物及其用途 |
EA024952B1 (ru) | 2011-04-21 | 2016-11-30 | Джилид Сайэнс, Инк. | Бензотиазолы и их применение для лечения вич-инфекции |
CN103827104A (zh) * | 2011-09-16 | 2014-05-28 | H.隆德贝克有限公司 | 双碳环和三碳环乙炔基衍生物及其应用 |
US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
US9284323B2 (en) | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
RU2014115227A (ru) | 2012-04-20 | 2015-10-27 | Джилид Сайэнс, Инк. | Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции |
US11083725B2 (en) | 2014-10-24 | 2021-08-10 | St. Jude Children's Research Hospital | Coordinated metabolic reprogramming in response to productive viral infections |
KR20180002748A (ko) * | 2015-05-05 | 2018-01-08 | 바이엘 파마 악티엔게젤샤프트 | 아미도-치환된 시클로헥산 유도체 |
WO2016205304A1 (fr) * | 2015-06-16 | 2016-12-22 | Signal Pharmaceuticals, Llc | Méthodes de traitement faisant appel à des composés de diaminopyrimidyle substitués |
TW201808903A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
TW201808914A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
TW201808888A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
TWI844006B (zh) * | 2016-05-05 | 2024-06-01 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
CA3066328A1 (fr) * | 2017-06-07 | 2018-12-13 | Glaxosmithkline Intellectual Property Development Limited | Composes chimiques utilises comme inhibiteurs de la voie atf4 |
EP3649106A1 (fr) * | 2017-07-03 | 2020-05-13 | GlaxoSmithKline Intellectual Property Development Limited | Dérivés de n-(3-(2-(4-chlorophénoxy)acétamido)bicyclo[1.1.1]pentan-1-yl)-2-cyclobutane-1-carboxamide et composés apparentés en tant qu'inhibiteurs atf4 pour le traitement du cancer et d'autres maladies |
EP3665156A4 (fr) | 2017-08-09 | 2021-04-28 | Denali Therapeutics Inc. | Composés, compositions et procédés |
AU2018358160B2 (en) | 2017-11-02 | 2023-03-16 | Abbvie Inc. | Modulators of the integrated stress pathway |
UY37956A (es) * | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
EP3704089B1 (fr) * | 2017-11-02 | 2023-07-19 | Calico Life Sciences LLC | Modulateurs de la voie de réponse intégrée au stress |
UY37957A (es) * | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
WO2019183589A1 (fr) * | 2018-03-23 | 2019-09-26 | Denali Therapeutics Inc. | Modulateurs du facteur 2 d'initiation eucaryote |
TWI771621B (zh) | 2018-10-11 | 2022-07-21 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
WO2020168011A1 (fr) | 2019-02-13 | 2020-08-20 | Denali Therapeutics Inc. | Composés, compositions et procédés |
EP3924341A4 (fr) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Composés, compositions et procédés |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2296310A1 (fr) | 1997-07-18 | 1999-01-28 | Werner Tuckmantel | Ligands des recepteurs bicycliques metabotropiques du glutamate |
PE20001236A1 (es) * | 1998-11-13 | 2000-11-10 | Lilly Co Eli | Moduladores del receptor de aminoacidos excitadores |
NZ515894A (en) | 1999-06-02 | 2003-09-26 | Nps Pharma Inc | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
EP1214303A1 (fr) | 1999-08-31 | 2002-06-19 | Merck & Co., Inc. | Composes heterocycliques et procedes d'utilisation de ceux-ci |
CA2390496A1 (fr) * | 1999-11-12 | 2001-05-17 | Biogen, Inc. | Polycycloalkylpurines comme antagonistes du recepteur d'adenosine |
GEP20094675B (en) | 2003-07-24 | 2009-05-10 | Euro Celtique Sa | Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain |
ES2433423T3 (es) * | 2008-07-25 | 2013-12-11 | H. Lundbeck A/S | Derivados de adamantil diamida y usos de los mismos |
TWI538905B (zh) * | 2010-12-22 | 2016-06-21 | H 朗德貝克公司 | 雙環[3.2.1]辛基醯胺衍生物及其用途 |
-
2011
- 2011-12-21 TW TW100147680A patent/TWI538905B/zh not_active IP Right Cessation
- 2011-12-21 AR ARP110104844A patent/AR084457A1/es unknown
- 2011-12-22 BR BR112013015592A patent/BR112013015592A8/pt not_active IP Right Cessation
- 2011-12-22 SG SG2013048558A patent/SG191317A1/en unknown
- 2011-12-22 GE GEAP201113166A patent/GEP20156219B/en unknown
- 2011-12-22 PE PE2013001463A patent/PE20141529A1/es not_active Application Discontinuation
- 2011-12-22 MY MYPI2013002338A patent/MY169432A/en unknown
- 2011-12-22 MA MA36100A patent/MA34819B1/fr unknown
- 2011-12-22 UA UAA201308888A patent/UA109802C2/uk unknown
- 2011-12-22 NZ NZ612000A patent/NZ612000A/en not_active IP Right Cessation
- 2011-12-22 MX MX2015011089A patent/MX349132B/es unknown
- 2011-12-22 EP EP11852103.8A patent/EP2654422B1/fr active Active
- 2011-12-22 EA EA201390908A patent/EA026362B1/ru not_active IP Right Cessation
- 2011-12-22 JP JP2013546401A patent/JP5992436B2/ja not_active Expired - Fee Related
- 2011-12-22 KR KR1020137016284A patent/KR101840076B1/ko active IP Right Grant
- 2011-12-22 CN CN201510626898.8A patent/CN105348185B/zh not_active Expired - Fee Related
- 2011-12-22 MX MX2013007104A patent/MX2013007104A/es active IP Right Grant
- 2011-12-22 CA CA2821937A patent/CA2821937A1/fr not_active Abandoned
- 2011-12-22 NZ NZ705710A patent/NZ705710A/en not_active IP Right Cessation
- 2011-12-22 CN CN201180067923.3A patent/CN103369961B/zh not_active Expired - Fee Related
- 2011-12-22 AU AU2011348188A patent/AU2011348188B2/en not_active Ceased
- 2011-12-22 WO PCT/US2011/066690 patent/WO2012088365A1/fr active Application Filing
- 2011-12-22 EP EP17178046.3A patent/EP3263566A1/fr not_active Withdrawn
- 2011-12-22 US US13/334,129 patent/US8921370B2/en not_active Expired - Fee Related
- 2011-12-22 AP AP2013006984A patent/AP3758A/en active
-
2013
- 2013-06-14 TN TNP2013000253A patent/TN2013000253A1/fr unknown
- 2013-06-16 IL IL226981A patent/IL226981A/en not_active IP Right Cessation
- 2013-06-19 DO DO2013000142A patent/DOP2013000142A/es unknown
- 2013-06-20 GT GT201300164A patent/GT201300164A/es unknown
- 2013-06-21 ZA ZA2013/04624A patent/ZA201304624B/en unknown
- 2013-06-21 CR CR20130309A patent/CR20130309A/es unknown
- 2013-07-17 CO CO13169779A patent/CO6741203A2/es unknown
- 2013-07-23 EC ECSP13012788 patent/ECSP13012788A/es unknown
-
2014
- 2014-08-18 ZA ZA2014/06059A patent/ZA201406059B/en unknown
- 2014-11-04 US US14/532,114 patent/US9656975B2/en not_active Expired - Fee Related
-
2016
- 2016-03-04 JP JP2016041981A patent/JP6087006B2/ja not_active Expired - Fee Related
- 2016-05-17 AU AU2016203192A patent/AU2016203192B2/en not_active Expired - Fee Related
-
2017
- 2017-04-18 US US15/489,971 patent/US20170217950A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA34819B1 (fr) | Dérivés bicyclo[3.2.1]octylamide et leurs utilisations | |
MA35749B1 (fr) | Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc | |
MA37891A1 (fr) | Alcoxypyrazoles comme activateurs de guanylate cyclase soluble | |
MA51204B1 (fr) | Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique | |
MA37400B1 (fr) | Composés hétérocyclyle en tant qu'inhibiteurs de mek | |
GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
MA34644B1 (fr) | Dérivés de pyrazole aminopyrimidine en tant que modulateurs du lrrk2 | |
MA35184B1 (fr) | Antagonistes de trpv4 | |
MA37142A3 (fr) | Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine | |
MA30821B1 (fr) | Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes | |
MA40225B1 (fr) | Composés dihydroisoquinolinone substitués | |
TW200628161A (en) | Novel betulin derivatives, preparation thereof and use thereof | |
MA33275B1 (fr) | Inhibiteurs de la replication du virus de l'immunodeficience humaine | |
MA31433B1 (fr) | Inhibiteurs de la p70 s6 kinase | |
MA38138A1 (fr) | Dérivés inédits de quinolone | |
BRPI0818193B8 (pt) | composto, composição farmacêutica, e, uso de um composto | |
MA35451B1 (fr) | Dérivés de pyrrolopyrimidine et de purine | |
RS20080533A (en) | Triazolopyrazine derivatives useful as anticancer agents | |
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
MA33734B1 (fr) | N1-pyrazolospirocétone inhibitrices d'acétyl-coa carboxylase | |
MA37886B1 (fr) | Nouvelles pyridinones bicycliques | |
MY151295A (en) | Pyrimidyl indoline compound | |
TN2011000654A1 (fr) | Sulfonamides heterocycliques leurs utilisations et compositions pharmaceutiques les contenant | |
MA33760B1 (fr) | Dérivés spirolactames et leurs utilisations | |
MA31142B1 (fr) | Derives heteroaryles de pyrrolidinyl et piperdinyl cetones. |